Psoriasis study demonstrates superiority of Novartis Cosentyx to Stelara in clearing skin
CLEAR is the second head-to-head study for Cosentyx following the phase III Fixture study that showed Cosentyx was superior to…
Author
People with blood groups A, B and AB at higher risk of type II diabetes than group O
A 35 per cent increased risk of type II diabetes was found in those with group B
Towards Holistic Healing
Express Pharma goes beyond allopathy in this special section, which looks at how age old remedies like ayurveda are being…
Potential of regenerative medicine
Application of stem cell-based therapies will be the turning point in the treatment of hitherto inadequately treated or incurable…
Ayurveda – A potential global medical system
The Government of India has recently drafted a national policy on traditional systems practiced in India. Shashank Sandu,…
Integrative medicine: An idea whose time has come
As the benefits of integrating ayurveda and allopathy, especially in the treatment of lifestyle diseases and post operative care…
Slower revenue growth at 6-quarter low in Q3FY15: CRISIL Research
Pharmaceuticals forecast to report above average topline growth
Type II diabetes treatment market value in Asia-Pacific to hit $10.5 billion by 2020: GBI Research
China will see the fastest expansion, with a CAGR of 11.1 per cent over the forecast period
Forecast 2015
As 2014 draws to a close, Express Pharma presents some hopes and predictions from thought leaders as they gaze into their crystal…
Jubilant Life Sciences, Lupin and Aurobindo Pharma receives US FDA approval for Valsartan tabs
Jubilant Life Sciences, Lupin and Aurobindo Pharma have received final approval from the US Food and Drug Administration (US FDA)…